Office-Wide Depression Screening with PHQ2 in an Urban PCMH: Implementation Challenges and Clinical Outcomes

Authors

Danielle Dang, MD, Thomas Jefferson University Hospital, Philadelphia, PAFollow
Elizabeth Collins, MD, Thomas Jefferson UniversityFollow
Lori Atkinson, MD, Thomas Jefferson University Hospital, Philadelphia, PAFollow
Zoe Agoos, MD, Thomas Jefferson UniversityFollow
Laura Emerson, MD, Thomas Jefferson UniversityFollow
Angela Silverman, MD, Thomas Jefferson UniversityFollow
Bryan Botti, MD, Thomas Jefferson UniversityFollow
Margaret Crenshaw, MD, Thomas Jefferson University Hospital, Philadelphia, PAFollow
Emily Levy, MD, Thomas Jefferson University Hospital, Philadelphia, PAFollow
Christopher Hwang, MD, Thomas Jefferson University Hospital, Philadelphia, PAFollow
Geoffrey Mills, MD, PhD, Thomas Jefferson UniversityFollow

Document Type

Presentation

Presentation Date

5-11-2016

Abstract

Presentation: 9:41

Recommended Citation

Dang, MD, Danielle; Collins, MD, Elizabeth; Atkinson, MD, Lori; Agoos, MD, Zoe; Emerson, MD, Laura; Silverman, MD, Angela; Botti, MD, Bryan; Crenshaw, MD, Margaret; Levy, MD, Emily; Hwang, MD, Christopher; and Mills, MD, PhD, Geoffrey, "Office-Wide Depression Screening with PHQ2 in an Urban PCMH: Implementation Challenges and Clinical Outcomes" (2016). Department of Family & Community Medicine Presentations and Grand Rounds. Paper 119.
https://jdc.jefferson.edu/fmlectures/119